摘要
Background:Agitation is common in people with dementia and negatively affects the quality of life of both people with dementia and carers.Non-drug patient-centred care is the first-line treatment,but there is a need for other treatment when this care is not effective.Current evidence is sparse on safer and effective alternatives to antipsychotics.We assessed the efficacy and safety of mirtazapine,an antidepressant prescribed for agitation in dementia.
出处
《四川生理科学杂志》
2021年第8期1381-1381,共1页
Sichuan Journal of Physiological Sciences
